Repligen Corp RGEN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
186.19UNCH (UNCH)
Volume
5,447
Close
186.19quote price arrow up+2.98 (+1.63%)
Volume
566,717
52 week range
78.41 - 228.84

...

Loading . . .

KEY STATS

  • Open183.21
  • Day High187.66
  • Day Low173.09
  • Prev Close183.21
  • 52 Week High228.84
  • 52 Week High Date02/12/21
  • 52 Week Low78.41
  • 52 Week Low Date03/23/20
  • Market Cap10.198B
  • Shares Out54.77M
  • 10 Day Average Volume0.41M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • 1 Year % Change97.09

RATIOS/PROFITABILITY

  • EPS (TTM)1.11
  • P/E (TTM)167.98
  • Fwd P/E (NTM)110.83
  • EBITDA (MRQ)112.104M
  • ROE (MRQ)4.63%
  • Revenue (MRQ)366.26M
  • Gross Margin (MRQ)57.23%
  • Net Margin (MRQ)16.36%
  • Debt To Equity (MRQ)15.94%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Repligen Corp News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It provides Protein A ligands, a component of Protein A chromatography resins (media) used in the purification of virtually all monoclonal antibody...
Karen Dawes
Chairman
Anthony Hunt
President
Jon Snodgres
Chief Financial Officer
Address
41 Seyon St Bldg 1 Ste 100
Waltham, MA
02453-8348
United States